CDC

US health panel reviews J&J vaccine pause over rare clots

By Lauran Neergaard and Mike Stobbe

U.S. authorities are weighing whether to resume the Johnson & Johnson vaccine more than a week after a pause was issued out of an abundance of caution. A government advisory panel is discussing a possible link between J&J’s shot and a handful of vaccine recipients who developed highly unusual blood clots. New guidance is expected later in the day.